Search the Newsreel

AngioDynamics (ANGO) SVP reports 3,838-share tax withholding event

AngioDynamics Inc. SVP/GM Vascular Access, Chad Thomas Campbell, reported tax-related dispositions of 3,838 shares of common stock. These shares were withheld over three separate dates (July 16, 17, and 20, 2026) to cover tax withholding obligations arising from the vesting of restricted stock units …

AngioDynamics (ANGO) Q4 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Tuesday, July 14, 2026 at 8:00 a.m. ET CALL PARTICIPANTS President and Chief Executive Officer - Jim ClemmerExecutive Vice President and Chief Financial Officer - Steve Trowbridge TAKEAWAYS Total Net Sales -- $86.6 million in the fourth quarter, …

Sanginita Chemicals independent director resigns

Sanginita Chemicals accepts resignation of Independent Director

ANGO Q2 2026 Earnings: Narrower Loss Surprises, but Stock Slides 4.46% - Operating Income Trends

AngioDynamics (NASDAQ:ANGO) Rating Lowered to "Strong Sell" at Zacks Research

AngioDynamics | SCHEDULE 13G/A: Others

This article is a SCHEDULE 13G/A filing for AngioDynamics, indicating an "Others" category. As a regulatory document, it provides required disclosure of beneficial ownership. The provided content indicates "Document", suggesting the full filing is linked or accessible elsewhere.

H.C. Wainwright raises AngioDynamics stock price target on growth

H.C. Wainwright has increased its price target for AngioDynamics (NASDAQ:ANGO) shares to $19 from $16, maintaining a Buy rating, following the company's strong fiscal fourth-quarter and full-year 2026 results. The medical technology firm reported significant growth in net sales, particularly in its Med Tech …

Full Transcript: AngioDynamics Q4 2026 Earnings Call

AngioDynamics reported strong Q4 fiscal year 2026 results with an 8% revenue increase to $86.6 million, driven by 16.7% growth in its MedTech segment, which now accounts for 47% of total revenue. The company highlighted 20 consecutive quarters of double-digit growth for its Aureon …

AngioDynamics (ANGO) Stock Faces Profitability Question As Q4 EPS Loss Deepens Bearish Narrative

AngioDynamics (ANGO) concluded FY 2026 with a Q4 basic EPS loss of US$0.27 and a full-year basic EPS loss of US$0.88 on US$320.2 million in revenue, continuing a trend of net losses. While forecasts project 72.2% annual earnings growth and profitability within three years, …

Freedom Broker raises AngioDynamics stock price target to $17 on margin outlook

Freedom Broker increased its price target for AngioDynamics (NASDAQ: ANGO) to $17.00 from $16.00, reiterating a Buy rating due to an improved margin outlook. This revision follows an upward adjustment of fiscal 2027 adjusted EBITDA estimates by 29% and expectations of growing margins from …

AngioDynamics Q4 Earnings Beat Estimates, Gross Margin Expands

AngioDynamics (ANGO) reported an adjusted loss per share of 7 cents for Q4 fiscal 2026, which was narrower than analysts' expectations, and full-year fiscal 2026 adjusted loss also beat estimates. The company's Q4 revenues rose 8% year-over-year to $86.6 million, exceeding the Zacks Consensus …

AngioDynamics (ANGO) Reports Q4 Loss, Beats Revenue Estimates

AngioDynamics (ANGO) reported a Q4 loss of $0.07 per share, outperforming the Zacks Consensus Estimate of a $0.11 loss, and exceeded revenue expectations with $86.61 million against an $80.16 million estimate. This marks the fourth consecutive quarter the company has surpassed both EPS and …

Sanginita Chemicals incorporates Agastya Solar Power subsidiary

Sanginita Chemicals open offer concludes with 68% stake

Sanginita Chemicals reclassifies promoters to public category

Sanginita Chemicals authorizes KMPs to determine materiality of events

Sanginita Chemicals allots shares to promoter at Rs 13.05

Sanginita Chemicals approves two wholly owned subsidiaries

Sanginita Chemicals Acquires Agastya Green Energy, Signaling Strategic Shift Toward India's Expanding Renewable Energy Market

Sanginita Chemicals allots shares to complete Agastya Green acquisition

Sanginita Chemicals open offer opens June 10 at ₹13.55

Sanginita Chemicals appoints new directors following open offer

Sanginita Chemicals open offer set at ₹13.55 per share

Sanginita Chemicals Announces Board Changes with New Appointments and Resignation

Would Sanginita Chemicals (NSE:SANGINITA) Be Better Off With Less Debt?

Sanginita Chemicals Ltd. Share Price Today - Sanginita Chemicals Ltd. Stock Price Live NSE/BSE

Sanginita Chemicals standalone net profit declines 69.57% in the December 2024 quarter